SEARCH

SEARCH BY CITATION

References

  • 1
    Bohannon, R. A., Miller, D. G., Diamond, H. D.: Vincristine in the treatment of lymphomas and leukemias. Cancer Res. 23: 613621, 1963.
  • 2
    Cohen, M. M., Shaw, M. W., and Craig, A. P.: The effects of streptonigrin on cultured human leukocytes. Proc. Natl. Acad. Sci. 50: 1624, 1963.
  • 3
    Harris, M. N., Medrek, Theodore J., Golomb, Frederick M., Gumport, S. L., Postel, A. H., and Wright, Jane C.: Chemotherapy with streptonigrin in advanced cancer. Cancer 18: 4957, 1965.
  • 4
    Hill, J. M., and Loeb, E.: Treatment of leukemia, lymphoma and other malignant neoplasms with Vinblastine. Cancer Chemother. Rep. 15: 41, 1961.
  • 5
    Humphrey, E. W., and Dietrich, F. S.: Clinical experience with the methyl ester of streptonigrin (NSC-45384). Cancer Chemother. Rep. 33: 2126, 1963.
  • 6
    Levine, M., and Borthwick, M.: The action of streptonigrin on bacterial DNA metabolism and on induction of phage production in lysogenic bacteria. Virology 21: 568574, 1963.
  • 7
    McBride, P. J., Oleson, J. J., and Woolf, D.: The action of streptonigrin against the Rauscher murine leukemia virus in vivo (abstr. 167). Proc. Am. Assn. Cancer Res. 6: 43, 1965.
  • 8
    Miller, D., Lazlo, J., McCarty, K. S., Hockstein, P., and Guild, W. R.: The action of streptonigrin on leukemic cell metabolism (abstr. 173). Proc. Am. Assn. Cancer Res. 6: 44, 1965.
  • 9
    Mizuno, N. S., and Humphrey, E. W.: Metabolism of tritiated methyl ester of streptonigrin (NSC-45384) in humans with cancer. Cancer Chemother. Rep. 41: 2326, 1964.
  • 10
    Phase II Protocol for the Study of Chemotherapeutic Agents in Solid Tumors. Prepared by the Cancer Chemotherapy National Service Center, National Institutes of Health, Bethesda, Maryland, 1961.
  • 11
    Rao, K. V.: Personal communication.
  • 12
    Rao, K. V., Bieman, K., and Woodard, R. B.: The structure of streptonigrin. J. Am. Chem. Soc. 85: 25322533, 1963.
  • 13
    Rao, K. V., and Cullen, W. P.: Streptonigrin, an antitumor substance—I. Isolation and characterization. Antibiotics Annual 7: 950953, 1959 –60.
  • 14
    Unpublished brochure: Preclinical Studies with Methyl Ester of Streptonigrin. John L. Smith Memorial for Cancer Research, Chas. Pfizer and Co., Inc., Maywood, New Jersey, under contract SA-43-ph-4396 from the Cancer Chemotherapy National Service Center, Collaborative Research, NCI, Public Health Service.
  • 15
    Whitelaw, D. M., and Teasdale, J. M.: Vincaleukoblastine in the treatment of malignant diseases. Canad. Med. Assn. J. 85: 584, 1961.